News Center

Discover all of the trending news of the Ipsen Group


12 results

People

Ipsen Named One of the Best Workplaces in Ireland

Ipsen was recognised as the 12th Best Medium Workplace in Ireland 2018. The Great Place…

Neuroscience Patient

LivingWithNETs.com awarded as Most valuable patient initiative by Eyeforpharma Awards 2018*

LivingWithNETs.com is a dedicated website for patients living with neuroendocrine tumors that was designed with…

Patient

International Childhood Cancer Day, Ipsen mobilizes its teams

The premise is that all children, no matter what their background, have dreams and aspirations.…

Financial information

Ipsen’s Full Year 2017 Financial Results

DAVID MEEK, CEO AYMERIC LE CHATELIER, EXECUTIVE VICE PRESIDENT, FINANCE WILL BE PRESENTING IPSEN’S FULL…

Oncology

Ipsen and Exelixis to host joint investor briefing on Phase 3 CELESTIAL trial results presented at ASCO GI

Ipsen and its partner Exelixis will jointly host a live investor briefing at the 2018…

Oncology

Ipsen at ASCO GI 2018

We are excited to be participating in the 2018 ASCO GI congress in San Francisco…

Event

Ipsen to present at the J.P. Morgan Healthcare Conference – January 10, 2018, at 10:00 am PST

David Meek, CEO will present at the J.P. Morgan Healthcare Conference  in San Francisco, California…

Group

Ipsen announces its corporate agenda for 2018

15 February 2018: Full year 2017 sales & results 26 April 2018: First quarter 2018…

Financial information

Ipsen delivers strong sales growth of 22.6% for the third quarter of 2017

Paris (France), 26 October 2017 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020